Tonix Pharmaceuticals (NASDAQ:TNXP) Enrols First Participant In PRECISION Study Evaluating Immune...

0
Tonix Pharmaceuticals Holdings Inc. (NASDAQ:TNXP) has enrolled its first participant in the observational PRECISION study, TNX-002. The study examines immune response to coronavirus in...

Amarin (NASDAQ:AMRN)Established That VASCEPA® can Reduce Ischemic Events In Individuals That...

0
Amarin Corporation Plc. (NASDAQ:AMRN) has announced the presentation of REDUCE-IT® PCI at Transcatheter Cardiovascular Therapeutics Connect during the 32nd Cardiovascular Research Foundation annual scientific...

Popular News

MAKE IT MODERN

LATEST REVIEWS

Axsome Therapeutics Inc. (NASDAQ:AXSM) Announces Development Status For AXS-05 In The...

0
There are hundreds of people facing unsatisfactory treatments for CNS disorders. Due to the limitation of treatment options, Axsome Therapeutics Inc (NASDAQ:AXSM) has taken...

MAKE IT MODERN

PERFORMANCE TRAINING

Preclinical studies of a COVID-19 vaccine by Altimmune Inc (NASDAQ:ALT) at UAB Shows Potent...

0
There are hundreds of preclinical studies of a COVID-19 vaccine currently under development. Those in the advanced stages include AdCOVID from Altimmune Inc (NASDAQ:ALT)....

Novus Therapeutics Inc. (NASDAQ:NVUS) Shares Tank After OP0201 Study In Acute Otitis Media Results...

0
Novus Therapeutics Inc. (NASDAQ:NVUS) shares lost almost 50% of its value after the company delivered disappointing results of its Phase 2a exploratory clinical study...

Altimmune Inc. (NASDAQ:ALT) Commences T-COVID Clinical Trial For Treatment Of Patients With Onset COVID-19...

0
Altimmune Inc. (NASDAQ:ALT) has announced that the FDA has given the company a go-ahead to proceed with its T-COVID clinical trial. T-COVID is Altimmune’s...

OSI Systems, Inc. (NASDAQ:OSIS) Bags $5 Million Order For The Supply Of Baggage Screening...

0
The commonwealth government of Australia awarded an order worth $5 million to OSI Systems, Inc. (NASDAQ:OSIS). As per the terms of the contract, OSI’s...

Incyte Corporation (NASDAQ:INCY) Reports Positive Overall Response Rates (ORR) From the GEOMETRY mono-1 Study...

0
Incyte Corporation (NASDAQ:INCY) has exceptional know-how in medicinal chemistry and biology. The global company was founded under a strong motivation, which defined the need...

MAKE IT MODERN

POPULAR

[/tdc_zone]

.td-post-views{ display: none !important; }